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ABSTRACT  
Setting: Clinical relevance of non-tuberculous mycobacteria (NTM) in Croatia is unknown.  
Objective: to estimate the isolation rate of NTM, record geographical differences, and assess the 
burden of pulmonary NTM disease. 
Design: nationwide retrospective cohort study on all Croatian residents with NTM isolated by culture 
in the period from 2006 through 2010. Microbiological criteria of the American Thoracic Society were 
used to establish a laboratory-based case definition of possible and probable NTM disease.  
Results: Out of 1187 people with pulmonary NTM isolates, 8.6% met the possible and 5.5% met the 
probable disease criteria. We estimated an annual incidence of probable pulmonary NTM disease of 
0.23/100,000. This estimated annual incidence was 0.35/100,000 in the coastal and 0.17/100,000 in 
the continental region. Species distribution differed between coastal and continental Croatia. NTM 
isolation frequency increased over the study period. 
Conclusion: Geography plays a role in NTM species distribution and possibly disease. The overall 
burden of NTM pulmonary disease in Croatia is still low compared to tuberculosis, but is higher in the 
coastal compared to the continental region.  
 
INTRODUCTION 
Nontuberculous mycobacteria (NTM) encompass all Mycobacterium species other than 
Mycobacterium tuberculosis complex and Mycobacterium leprae. There are currently more than 140 
species of these environmental, mostly opportunistic pathogens [1]. Recently, these organisms have 
gained increased attention, due to increases in the isolation frequency of NTM [1-5]. This increase is 
thought to be most pronounced in countries where the incidence of tuberculosis (TB) is declining [1, 
6]. The exact epidemiology of pulmonary NTM disease has been difficult to determine because 
reporting is not mandatory in most countries and identification of true disease is often difficult [1, 7]. 
Laboratory based surveillance may be the most cost-effective method for estimating NTM disease 
burden over time [8, 9]. A systematic review of NTM epidemiology as well as estimation of disease 
burden in countries with intermediate TB burden such as Croatia [10] is lacking. In the current study, 
we have aimed to calculate the population-based NTM isolation frequency, examine geographical 
differences in species distribution and estimate burden of pulmonary NTM disease in Croatia. 
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METHODS 
Study design. We conducted a retrospective cohort study using laboratory data on all Croatian 
residents with NTM isolated from respiratory samples by culture in the period from 2006 through 
2010. Gastric lavages were excluded from further analysis. Only one isolate per individual was taken 
into account when calculating NTM isolation rate frequency. For disease incidence, we took into 
account only the first time that defined disease criteria were met. For individuals meeting those 
criteria, we looked into the data from the year 2005 in order to exclude those with previously 
isolated NTM from disease incidence calculation. If multiple NTM species were cultivated from 
samples of one individual, each species was counted as a separate isolate.   
Data collection. In Croatia, all NTM isolates are sent to the National Reference Laboratory (NRL) for 
identification. From the archive of the NRL, we obtained information on every Croatian resident with 
NTM isolated in the study period. For each isolate, we recorded patient age, address, zip code, 
specimen collection date and source, and NTM species isolated. By using the zip code, patients were 
grouped into two larger areas according to the proximity of the sea: coastal and continental region of 
Croatia. The Croatian population data which included population by region, age and sex, was 
obtained from The Statistical Office of the European Communities (Eurostat) [11] and was used for 
crude and age standardized (European standard population) rate estimations.  
 
Identification of NTM: All NTM were identified by molecular methods (GenoType© CM/AS; Hain 
Lifescience, Nehren, Germany) supplemented with phenotypic methods, using previously published 
guidelines [12]. NTM, unidentifiable to species level, were sent to Supranational Reference 
Laboratories (Forschungszentrum Borstel, Germany or Emerging Pathogens Institute, Milano, Italy) 
for further identification by 16S rRNA gene sequencing.  
Pulmonary NTM disease case definition: Due to the lack of clinical data, we used the American 
Thoracic Society (ATS), and Infectious Diseases Society of America (IDSA) microbiological criteria [1] 
to establish a laboratory-based case definition of probable, possible and unlikely NTM disease. We 
defined possible NTM disease as two positive sputums or one positive bronchial lavage (BAL) or 
brush. Probable NTM disease was defined as more than two positive sputum samples or one positive 
BAL/brush and one or more positive sputum samples.  
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Data analysis. Microsoft Excel (Microsoft, Redmond, Washington) was used to calculate frequencies, 
percentages, median age, crude and standardized rates. Chi-square and chi-square test for trend test 
as well as rate comparisons were done using MedCalc (MedCalc Software, Mariakerke, Belgium). 
 
RESULTS 
During the study period, the total number of samples of pulmonary origin sent to the NRL for analysis 
decreased from 57209 samples in the year 2006 to 42223 samples in the year 2010. The total 
numbers of all isolated Mycobacterium spp. (TB and NTM combined), as well as the number of NTM 
isolates of pulmonary origin, are shown in Figure 1. The average population of Croatia during the 
study period was 4,437,538 with two thirds living in the continental region. 
 
Pulmonary isolates  
NRL identified a total of 1710 pulmonary NTM isolates of 24 species from 1187 individuals. Among 
those 1187 patients, M. gordonae was the most frequent isolate, followed by M. xenopi, M. 
fortuitum, M. terrae and M. avium (Table 1). Over 80% of all NTM isolates originated from patients in 
continental Croatia (Table 1). The species distribution differed between coastal and continental 
Croatia: M. vaccae (p=0.05), M. terrae (p<0.001), M. fortuitum (p=0.012),M. gordonae (p<0.001) and 
rapidly growing mycobacteria (RGM) as a group (p=0.003) were significantly more frequent in 
continental Croatia, while M. xenopi (p<0.001), M. lentiflavum (p<0.001) and M. avium (p<0.001) 
were associated with the coastal region (Figure 2). 
Of 1187 patients with NTM isolates, 59% were men and 41% were women with median ages of 64 
and 66. M. avium was more often found in women (p=0.031), while M. xenopi appeared less 
common in women than in men (p=0.002) (Table 1). Among patients aged >50 years, NTM isolation 
rates were significantly higher in men than in women (p<0.001; Figure 3). After age stratification, the 
increasing trend of NTM isolation incidence was observed in the population over 50 years of age 
living in the continental region of Croatia (data not shown). The annual isolation frequency of the 
most common NTM species (30 or more individual isolates in 5-year period), are shown in Figure 4.  
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Pulmonary disease  
The most frequently isolated NTM species that met the defined microbiologic criteria for probable or 
possible disease are shown in Table 1. Of 1187 patients with NTM pulmonary isolates, 102 (8.6%) and 
65 (5.5%) met the possible and probable disease criteria, respectively. Demographic characteristics of 
these two groups are shown in Table 2. Whereas M. xenopi disease was most frequently seen, clinical 
relevance (i.e. percentage of patients meeting the criteria for either possible or probable disease, per 
species) was higher for M. intracellulare (9/23; 60.9%), M. avium (24/42; 57.1%), M. kansasii (5/10; 
50%) and M. lentiflavum (2/5; 40%). Of the RGM, M. abscessus was noted as having the highest 
clinical relevance (8/30; 26.7%). When taking into account only isolates meeting the probable disease 
criteria, the clinical relevance was highest for M. kansasii (4/10; 40%), M. intracellulare (8/23; 34.8%), 
M. avium (14/42; 33.3%) and M. xenopi (21/184; 11.4%). Clinical relevance of M. gordonae isolates 
was low, with only 1% of all patients with M. gordonae isolates meeting criteria for probable disease.  
The overall estimated age-standardised annual incidence of NTM pulmonary disease amounts to 
0.60/100,000. Taking into account only the probable disease group, the estimated annual incidence 
would be 0.23/100,000. The incidence of true pulmonary NTM disease differs between the coastal 
and continental region of Croatia. The percentage of patients meeting either possible or probable 
disease criteria was 25.3% in the coastal region and 11.4% in the continental region. The percentage 
of people meeting the probable disease criteria was 14.2% in the coastal region, compared to only 
3.4% in the continental region. The incidence and prevalence of probable pulmonary NTM disease 
were 0.35/100.000 and 1.11/100,000 in the coastal region, but only 0.17/100,000 and 0.23/100,000 
in the continental region.  
After age stratification, 56 (86.2%) of all probable disease cases and 81 (79.4%) of all possible disease 
cases belonged to the 50+ age group (Table 2). The annual incidence of combined possible and 
probable disease in the 50+ age group was estimated at 1.69/100,000 with an increasing trend 
observed over the study period. 
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DISCUSSION 
This is the first study showing the isolation frequency of NTM species from pulmonary samples in 
Croatia and estimating the nationwide pulmonary NTM disease incidence through the use of 
comprehensive laboratory data. This is also one of the rare studies on NTM incidence in a country 
with intermediate TB burden. Croatia's TB incidence rates were 26/100,000 and 17/100,000 in 2006 
and 2010 [10].  
Pulmonary isolates 
The NTM species distribution differed between the coastal and continental region. An increase in 
NTM isolation frequency was observed for the study period with a peak in the year 2009. This 
increase was mostly based on increased isolation of M. gordonae and M. fortuitum (Figure 3), and a 
peak in 2009 could be explained by a subsequently established contamination of tap water 
(presumably consumed by patients before giving sputum sample) with M. gordonae in a single centre 
(V. Katalinic Jankovic, personal communication). Furthermore, the increasing trend of NTM isolation 
frequency was observed only in the population over 50 years of age living in the continental region of 
Croatia (data not shown). This increase thus involves mainly clinically irrelevant isolates [1, 13]. 
Several recent studies from North America and Western Europe all showed a significant increase of 
total NTM isolation rates [2-5]. In the study from the Netherlands, the increase was mainly caused by 
a rise in M. avium and M. gordonae isolates from pulmonary samples and it was most pronounced in 
patients >40 years old [3]. A study from the UK showed that the increase in NTM reports was mainly 
in pulmonary specimens and people aged >60 years, with M. gordonae showing the biggest increase 
but MAC remaining the most commonly reported species [14]. In Denmark, the rising trend in NTM 
isolation was less obvious but the incidence of NTM disease had increased, especially in elderly [4].  
The NTM species that are cultured from clinical samples differ strongly by region [6]. We found 
interesting regional differences. Even though the majority of all NTM isolates came from continental 
Croatia, most of those were species generally considered of low virulence [1, 13]. In contrast, 
clinically relevant NTM isolates were significantly more often found in the coastal region of Croatia. 
The species distribution in pulmonary samples is recorded in Figure 4. Some of the factors that might 
promote these observed regional differences in Croatia include the climate, rate of urbanization and 
TB incidence [15]. The urbanized coastal region has wetter and warmer climate and relies on larger 
municipal water supplies, compared to the more rural, continental part of Croatia where more 
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households use well water. Furthermore, the incidence of TB was lower in coastal region 
(21.2/100,000) than in the continental region of Croatia (30.1/100,000) in 2006 [10].  
Pulmonary disease 
We relied solely on microbiologic criteria to assign patients with isolated NTM to three groups – 
probable, possible, and unlikely disease. We used this approach since it was previously shown that 
microbiologic criteria are highly predictive of disease and are useful for laboratory-based NTM 
disease surveillance [8, 9].  
The data observed in this study are consistent with the earlier described epidemiology of M. xenopi 
infection in Croatia [16]. However, despite the high frequency of M. xenopi isolation, M. avium, M. 
intracellulare, and M. kansasii were more strongly associated with pulmonary NTM disease 
compared to M. xenopi. This differs from observations in the Netherlands, where M. xenopi and M. 
kansasii were more strongly associated with disease than M. avium and M. intracellulare [13], 
applying the full ATS diagnostic criteria [1]. The background of such apparent regional differences 
remains unknown. 
Taking into account all individuals meeting the microbiologic criteria, we estimated annual incidence 
of NTM pulmonary disease at 0.60/100,000. However, the number of cases of M. gordonae disease is 
likely overestimated, since it is known to rarely cause true disease [1, 13]. Discarding all of the M. 
gordonae cases, the annual incidence would be 0.38/100,000. Furthermore, taking into account the 
probable disease group only, the annual incidence decreases to 0.23/100,000 with most of the cases 
due to M. xenopi, M. avium, M. intracellulare, M. kansasii and M. abscessus. 
The incidence of NTM pulmonary disease in Croatia is low compared to its TB incidence and to NTM 
data from North-Western Europe. In the Netherlands, the incidence of NTM disease has been 
estimated at 1.7/100,000 in 2008 [17] while in Denmark the incidence of true disease reached 
1.08/100,000 [4]. A study from New Zealand, using methodology similar to ours, estimated 
pulmonary NTM disease incidence to be 1.2/100,000 and found a majority (79%) of cases to be 
women [18]. We found no significant gender differences in NTM pulmonary disease cases (Table 2). 
The incidence of TB in Croatia is higher than in North-Western Europe and New Zealand, and Bacillus 
Calmette-Guerin (BCG) vaccination is still mandatory. This may explain the lower NTM isolation and 
Jankovic, M., Samarzija, M., Sabol, I., Jakopovic, M., Katalinic Jankovic, V., Zmak, L., Ticac, B., Marusic, A., Obrovac, M., van 
Ingen, J., 2013. Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia. The 
International Journal of Tuberculosis and Lung Disease 17, 836–841. doi:10.5588/ijtld.12.0843 – Accepted Version 
 
9 
 
disease rates since it has been speculated that infection with TB and BCG vaccination may provide 
cross-immunity to NTM infection [19].  
We observed that a higher percentage of patients living in coastal Croatia met the defined disease 
criteria, compared to those living in continental Croatia. Moreover, the estimated annual incidence in 
coastal region is twice as high as in the continental region. This might be a reflection the species 
distribution in these two regions but further research is needed to fully understand the observed 
differences. A recent study in the USA showed that regional environmental factors related to soil and 
differences in daily evapotranspiration levels are associated with pulmonary NTM disease, but that 
both host susceptibility and environmental factors should be considered in explaining disease 
development [20]. 
The limitation of this study is the lack of clinical and radiological data. The used methodology could 
cause disease overestimation (e.g. for M. gordonae). On the other hand, disease incidence could also 
be underestimated in case of having only one sputum sample sent to the laboratory for identification 
with no follow-up testing. We applied the possible and probable disease criteria to increase the 
strength of solely using the microbiologic criteria. Also, it is possible that incidence of NTM disease is 
slightly overestimated given that some of the patients classified as “incident cases” in 2006, might 
have had NTM isolated prior to the study period. We tried to minimise this error by looking into the 
available data from the year 2005, and excluding the recurrent cases from the disease incidence 
calculation.  
In summary, we have shown that the NTM species distribution as well as the incidence of pulmonary 
NTM disease significantly differs between the coastal and continental region of Croatia. NTM 
pulmonary disease is strongly associated with age and more often affects males, but the burden of 
disease remains low compared to TB. Annual incidence amounts to 0.60/100,000, or 0.23/100,000 if 
restricted to probable disease only. The isolation frequency slightly rose throughout the study 
period. 
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Table 1. Non-tuberculous mycobacteria (NTM) isolation frequency in Croatia according to gender, 
geographic region and microbiologic criteria  
NTM species 
  
Geographic region Gender Microbiologic criteria 
Total (%) 
Continental 
total (%) 
Coastal 
total (%) 
Female 
total (%) 
Male  
total (%) 
Probable 
disease* 
total (%) 
Possible 
disease* 
total (%) 
Unlikely 
disease* 
total (%) 
M. gordonae 509 (42.9) 437 (45.5) 72 (32) 219 (45) 290 (41.5) 5 (7.7) 29 (28.4) 475 (46.6) 
M. xenopi 184 (15.5) 108 (11.2) 76 (33.8) 57 (11.7) 127 (18.2) 21 (32.3) 26 (25.5) 137 (13.4) 
M. fortuitum 136 (11.5) 121 (12.6) 15 (6.7) 48 (9.9) 88 (12.6) 3 (4.6) 16 (15.7) 117 (11.5) 
M. terrae 93 (7.8) 89 (9.3) 4 (1.8) 47 (9.7) 46 (6.6) 0 (0) 4 (3.9) 89 (8.7) 
M. avium 42 (3.5) 23 (2.4) 19 (8.4) 24 (4.9) 18 (2.6) 14 (21.5) 10 (9.8) 18 (1.8) 
M. abscessus 30 (2.5) 26 (2.7) 4 (1.8) 13 (2.7) 17 (2.3) 3 (4.6) 5 (4.9) 22 (2.2) 
M. intracellulare 23 (1.9) 16 (1.7) 7 (3.1) 10 (2) 13 (1.9) 8 (12.3) 1 (1) 14 (1.4) 
M. kansasii 10 (0.8) 6 (0.6) 4 (1.8) 4 (0.8) 6 (0.9) 4 (6.2) 1 (1) 5 (0.5) 
Other NTM 159 (13.5) 135 (14) 24 (10.7) 65 (13.3) 94 (13.4) 7 (10.8) 10 (9.8) 142 (13.9) 
Total 1186 (100) 961 (100) 225 (100) 487 (100) 699 (100) 65 (100) 102 (100) 1019 (100) 
 
Probable disease* 
(%) 
65 (100%) 33 (51) 32 (49) 31 (47.7) 34 (52.3) 
Possible disease* 
(%) 
102 (100%) 77 (75.5) 25 (24.5) 44 (43.1) 58 (56.9) 
Unlikely disease* 
(%) 
1019 (100%) 851 (83.5) 168 (16.5) 412 (40.4) 607 (59.6) 
 
*  Possible disease: either two positive sputums, or one positive bronchial lavage (BAL) or brush 
Probable disease: more than two positive sputum samples; one positive BAL/brush and one or 
more positive sputum samples.  
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Table 2. Demographic characteristics of patients meeting the microbiologic criteria of probable and 
possible pulmonary non-tuberculous mycobacteria (NTM) disease* per year per 100.000 population in 
Croatia  
 Probable Disease* Possible disease*  
Cases 
Value  
(percent) 
Median 
age 
Annual 
incidence 
Value 
(percent) 
Median 
age 
Annual 
incidence 
Average 
population 
All cases 65 (100)  66 0,23** 102 (100)  65 0,38** 4436265 
Gender          
Female 31 (47.7)  66 0,20** 44 (43.1)  62 0,33** 2297905 
Male 34 (52.3)  64.5 0,21** 58 (56.9)  65.5 0,37** 2138360 
Age          
0-9 0  0  4 (3.9) 4.5 0,18 432,458 
10-19 0  0  4 (3.9) 14 0,15 517,389 
20-29 2 (3.1) 21 0,07 2 (2) 27 0,07 607,393 
30-39 2 (3.1) 33 0,07 5 (4.9) 37 0,17 597,061 
40-49 3 (4.6) 49 0,09 6 (5.9) 44.5 0,19 641,701 
50-59 16 (24.6) 56.5 0,51 20 (19.6) 55.5 0,63 632,411 
60-69 15 (23.1) 66 0,65 25 (24.5) 66 1,08 461,805 
70-79 17 (26.2) 73 0,89 28 (27.5) 74 1,46 383,530 
80+ 8 (12,3) 85 1,12 8 (7.8) 82 1,12 143,306 
Unknown 2 (3.1)   0     
50+ 56 (86.2)  68 0,69 81 (79.4)  68 1 1,621,052 
 
Geographic 
location          
Continental 33 (50.1) 69 0,17** 77 (75.5) 60 0,44** 2,971,550 
Coastal 32 (49.9) 64.5 0.35** 25 (24.5) 68 0,25** 1,464,715 
 
*  Possible disease: either two positive sputums, or one positive bronchial lavage (BAL) or brush 
Probable disease: more than two positive sputum samples; one positive BAL/brush and one or 
more positive sputum samples.  
**  Age standardized incidence rates 
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Figure 1. Total number of Mycobacterium spp., Mycobacterium tuberculosis and pulmonary non-
tuberculous mycobacteria (NTM) isolates submitted to the National Reference Laboratory during the study 
period. 
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Figure 2. The distribution of non-tuberculous mycobacteria (NTM) species isolated from pulmonary samples 
in the coastal and continental region of Croatia 
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Figure 3. Crude non-tuberculous mycobacteria (NTM) isolation frequency rate per 100.000 population 
stratified by age and gender 
 
M – male; F - female 
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Figure 4. Isolation frequency rate of the most common non-tuberculous mycobacteria (NTM) species in 
Croatia per year per 100.000 population  
 
 
 
